After claiming its approval in Europe earlier this year, Abbott has secured the FDA’s go-ahead for its Volt pulsed field ablation system for irregular heart rhythms, a step forward in an | With the U.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback